BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 30496320)

  • 1. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease.
    Olney NT; Bischof A; Rosen H; Caverzasi E; Stern WA; Lomen-Hoerth C; Miller BL; Henry RG; Papinutto N
    PLoS One; 2018; 13(11):e0208255. PubMed ID: 30496320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times.
    Papinutto N; Schlaeger R; Panara V; Caverzasi E; Ahn S; Johnson KJ; Zhu AH; Stern WA; Laub G; Hauser SL; Henry RG
    J Magn Reson Imaging; 2015 Sep; 42(3):698-708. PubMed ID: 25483607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical and thoracic spinal cord gray matter atrophy is associated with disability in patients with amyotrophic lateral sclerosis.
    Wendebourg MJ; Weigel M; Weidensteiner C; Sander L; Kesenheimer E; Naumann N; Haas T; Madoerin P; Braun N; Neuwirth C; Weber M; Jahn K; Kappos L; Granziera C; Schweikert K; Sinnreich M; Bieri O; Schlaeger R
    Eur J Neurol; 2024 Jun; 31(6):e16268. PubMed ID: 38465478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Intra- and Interscanner Reliability of MRI Protocols for Spinal Cord Gray Matter and Total Cross-Sectional Area Measurements.
    Papinutto N; Henry RG
    J Magn Reson Imaging; 2019 Apr; 49(4):1078-1090. PubMed ID: 30198209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
    Schlaeger R; Papinutto N; Zhu AH; Lobach IV; Bevan CJ; Bucci M; Castellano A; Gelfand JM; Graves JS; Green AJ; Jordan KM; Keshavan A; Panara V; Stern WA; von Büdingen HC; Waubant E; Goodin DS; Cree BA; Hauser SL; Henry RG
    JAMA Neurol; 2015 Aug; 72(8):897-904. PubMed ID: 26053119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease.
    van der Burgh HK; Westeneng HJ; Meier JM; van Es MA; Veldink JH; Hendrikse J; van den Heuvel MP; van den Berg LH
    Neuroimage Clin; 2019; 24():101984. PubMed ID: 31499409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal cord gray matter atrophy correlates with multiple sclerosis disability.
    Schlaeger R; Papinutto N; Panara V; Bevan C; Lobach IV; Bucci M; Caverzasi E; Gelfand JM; Green AJ; Jordan KM; Stern WA; von Büdingen HC; Waubant E; Zhu AH; Goodin DS; Cree BA; Hauser SL; Henry RG
    Ann Neurol; 2014 Oct; 76(4):568-80. PubMed ID: 25087920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI signatures of the frontotemporal lobar degeneration continuum.
    Agosta F; Galantucci S; Magnani G; Marcone A; Martinelli D; Antonietta Volontè M; Riva N; Iannaccone S; Ferraro PM; Caso F; Chiò A; Comi G; Falini A; Filippi M
    Hum Brain Mapp; 2015 Jul; 36(7):2602-14. PubMed ID: 25821176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Region-specific impairment of the cervical spinal cord (SC) in amyotrophic lateral sclerosis: A preliminary study using SC templates and quantitative MRI (diffusion tensor imaging/inhomogeneous magnetization transfer).
    Rasoanandrianina H; Grapperon AM; Taso M; Girard OM; Duhamel G; Guye M; Ranjeva JP; Attarian S; Verschueren A; Callot V
    NMR Biomed; 2017 Dec; 30(12):. PubMed ID: 28926131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spinal Cord Gray Matter Atrophy in Amyotrophic Lateral Sclerosis.
    Paquin MÊ; El Mendili MM; Gros C; Dupont SM; Cohen-Adad J; Pradat PF
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):184-192. PubMed ID: 29122760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
    Xiang B; Wen J; Cross AH; Yablonskiy DA
    J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: A combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis.
    Christidi F; Karavasilis E; Riederer F; Zalonis I; Ferentinos P; Velonakis G; Xirou S; Rentzos M; Argiropoulos G; Zouvelou V; Zambelis T; Athanasakos A; Toulas P; Vadikolias K; Efstathopoulos E; Kollias S; Karandreas N; Kelekis N; Evdokimidis I
    Brain Imaging Behav; 2018 Apr; 12(2):547-563. PubMed ID: 28425061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord multi-parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis.
    Querin G; El Mendili MM; Lenglet T; Delphine S; Marchand-Pauvert V; Benali H; Pradat PF
    Eur J Neurol; 2017 Aug; 24(8):1040-1046. PubMed ID: 28586096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical spinal cord atrophy in amyotrophic lateral sclerosis across disease stages.
    Nigri A; Dalla Bella E; Ferraro S; Medina Carrion JP; Demichelis G; Bersano E; Consonni M; Bischof A; Stanziano M; Palermo S; Lauria G; Bruzzone MG; Papinutto N
    Ann Clin Transl Neurol; 2023 Feb; 10(2):213-224. PubMed ID: 36599092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study.
    Bede P; Chipika RH; Finegan E; Li Hi Shing S; Doherty MA; Hengeveld JC; Vajda A; Hutchinson S; Donaghy C; McLaughlin RL; Hardiman O
    Neuroimage Clin; 2019; 24():102054. PubMed ID: 31711033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel MRI Biomarker of Spinal Cord White Matter Injury: T2*-Weighted White Matter to Gray Matter Signal Intensity Ratio.
    Martin AR; De Leener B; Cohen-Adad J; Cadotte DW; Kalsi-Ryan S; Lange SF; Tetreault L; Nouri A; Crawley A; Mikulis DJ; Ginsberg H; Fehlings MG
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1266-1273. PubMed ID: 28428212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state.
    Kim HJ; Oh SI; de Leon M; Wang X; Oh KW; Park JS; Deshpande A; Buj M; Kim SH
    Eur J Neurol; 2017 Jan; 24(1):122-129. PubMed ID: 27753163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates.
    Vinceti G; Olney N; Mandelli ML; Spina S; Hubbard HI; Santos-Santos MA; Watson C; Miller ZA; Lomen-Hoerth C; Nichelli P; Miller BL; Grinberg LT; Seeley WW; Gorno-Tempini ML
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):146-158. PubMed ID: 30668155
    [No Abstract]   [Full Text] [Related]  

  • 19. Gray matter segmentation of the spinal cord with active contours in MR images.
    Datta E; Papinutto N; Schlaeger R; Zhu A; Carballido-Gamio J; Henry RG
    Neuroimage; 2017 Feb; 147():788-799. PubMed ID: 27495383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking White and Gray Matter Degeneration along the Spinal Cord Axis in Degenerative Cervical Myelopathy.
    Vallotton K; David G; Hupp M; Pfender N; Cohen-Adad J; Fehlings MG; Samson RS; Wheeler-Kingshott CAMG; Curt A; Freund P; Seif M
    J Neurotrauma; 2021 Nov; 38(21):2978-2987. PubMed ID: 34238034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.